Publications

Publications

Promoting consultation recording practice in oncology: identification of critical implementation factors and determination of patient benefit.

By:
Contributors: Dean Ruether, MD FRCSC

Psychooncology. 2013 Jun;22(6):1273-82. doi: 10.1002/pon.3135. Epub 2012 Jul 23.

Hack TF1, Ruether JD, Weir LM, Grenier D, Degner LF.

Abstract

OBJECTIVE:

The objectives of this implementation study were to (i) address the evidentiary, contextual, and facilitative mechanisms that serve to retard or promote the transfer and uptake of consultation recording use in oncology practice and (ii) follow patients during the first few days following receipt of the consultation recording to document, from the patient‘s perspective, the benefits realized from listening to the recording.

METHODS:

Nine medical and nine radiation oncologists from cancer centers in three Canadian cities (Calgary, Vancouver, and Winnipeg) recorded their primary consultations for 228 patients newly diagnosed with breast (n = 174) or prostate cancer (n = 54). The Digital Recording Use Semi-Structured Interview was conducted at 2 days and 1 week postconsultation. Each oncologist was provided a feedback letter summarizing the consultation recording benefits reported by their patients.

RESULTS:

Sixty-nine percent of patients listened to at least a portion of the recording within the first week following the consultation. Consultation recording favorableness ratings were high: 93.6% rated the intervention between 75 and 100 on a 100-point scale. Four main areas of benefit were reported: (i) anxiety reduction; (ii) enhanced retention of information; (iii) better informed decision making; and (iv) improved communication with family members. Eight fundamental components of successful implementation of consultation recording practice were identified.

CONCLUSIONS:

Further randomized trials are recommended, using standardized measures of the patient-reported benefit outcomes reported herein, to strengthen the evidence base for consultation recording use in oncology practice.

 PubMed

Download PDF

 

Stay Informed

To stay up to date on all the latest news and publications, subscribe to our newsletter!

The Alberta Prostate Cancer Biorepository is certified by CTRNet

APCaRI is committed to collecting, processing and storing the samples you donate with the highest quality standards and as a result, after evaluation of our processes, the CTRNet (Canadian Tissue Repository Network) awarded us with their certification.

CTRNet is a translational cancer research resource, funded by Canadian Institutes of Health Research, that furthers Canadian health research by linking cancer researchers with provincial tumour banks.

The benefits of working with CTRNet include:

  • The ability for researchers to search for quality controlled tissue samples from Canada’s leading tumour banks in one central location and for biobanks to display and make their biospecimens available for research users.
  • Learning opportunities in tissue handling, research design and relevant technology training and innovations.
  • Invitation to CTRNet workshops and conferences.
- Catalina Vasquez